fetal akinesia syndrome, X-linked

Summary

fetal akinesia syndrome, X-linked (MONDO:0010242) is a disease. A subtype of fetal akinesia deformation sequence — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	fetal akinesia syndrome, X-linked
Mondo ID	MONDO:0010242
MeSH	C537921
OMIM	300073
DOID	DOID:0081043
UMLS	C1848171
MedGen	341166
GARD	0002293
Is cancer (heuristic)	no

Also known as: fetal akinesia syndrome X-linked · fetal akinesia syndrome, X-linked · foetal akinesia syndrome X-linked · polyhydramnios, hypokinesia, brain malformations, telecanthus, and narrow palpebral fissures · X-linked form of fetal akinesia syndrome · X-linked form of foetal akinesia syndrome

Disease family

This is a subtype of fetal akinesia deformation sequence. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › syndromic disease › fetal akinesia deformation sequence › fetal akinesia syndrome, X-linked

Related subtypes (4): fetal akinesia deformation sequence 1, fetal akinesia deformation sequence 2, fetal akinesia deformation sequence 3, fetal akinesia deformation sequence 4

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.